DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
Clinical trial NCT02973269 · TERMINATED
Trial details
- NCT number
- NCT02973269
- Sponsor
- Revance Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2017-05-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.